From being late adopters of disruptive technologies, the pharmaceutical and life sciences industry has come to a phase where in they are at the luxury to choose from a plethora of solution providers, with multiple innovations at their disposal. Driving factors for this exponential increase in innovation include a rise in the R&D activities by various pharma and biopharma companies, growing application of software solutions in medical trials, and rising government funding for promoting clinical research programs. And in increasingly digital environments, successful trials require collaboration, digital knowledge and patient engagement. As such, the CTMS market is projected to grow at a CAGR of 11.5 percent in the next four years.
March 2017| View Digital Version
Silji Abraham, CIO, MilliporeSigma
Benson Hsu, Vice President, Data and Analytics, Sanford Health
Marc Probst, CIO and VP, Intermountain Healthcare
Eric Perakslis, Sr. VP, Informatics, Takeda Pharmaceutical Company Limited
Pracha Eamranond, Senior VP, Medical Affairs and Population and Meghan O’Neill, Project Manager in Information Systems, Lawrence General Hospital
Michelle Woodley, Chief Nursing Information Officer, St. Joseph Health
Paul Shawah, VP, Commercial Cloud Strategy, Veeva Systems and President at Align Bio-pharma
Scott Lust, Senior Consultant in Clinical Operations at Fuse by Cardinal Health and Brent Stutz, SVP of Commercial Technologies at Cardinal Health
Charlton Park, Chief Analytics Officer at University of Utah Hospitals and Clinics
Bob Oliver, President and CEO, Otsuka America Pharmaceutical, Inc.
Pharma and life sciences industry is in a state of flex. The introduction of far-reaching Patient
From inception to completion of a trial life cycle, data managers are implementing Clinical Data
July - August 2016
In todays data-driven era, sophisticated technology tools are bringing data and people together to